GlassScriptPhysician profile
John D Duerden
NPI 1922195858
$5,596.01
in general payments reported to CMS, 2019-2025
27 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $3,416 · 2021: $437 · 2022: $462 · 2023: $363 · 2024: $220 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,258.24 | 2020 | |
| Bioventus LLC | $665.13 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Durolane |
| Fortis Surgical, LLC | $545.15 | 2019-2024 | |
| Medtronic, INC. | $146.61 | 2023 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $125.82 | 2022 | |
| Kci USA, INC. | $98.72 | 2021 | |
| Dynasplint Systems INC. | $77.61 | 2023-2025 | Dynasplint |
| Abbott Laboratories | $74.44 | 2021-2022 | |
| Fidia Pharma USA INC. | $69.68 | 2022-2023 | Hymovis |
| Convatec INC. | $59.40 | 2023-2024 | |
| Stryker Corporation | $56.20 | 2024-2025 | Augment Injectable, Variax, Citrefix |
| Lifenet Health | $55.62 | 2025 | Theragenesis Wound Matrix |
| Radius Health, INC. | $48.99 | 2024 | Tymlos |
| Restor3d, INC. | $36.35 | 2023 | |
| Si-Bone, INC. | $33.87 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $33.28 | 2024 | Painteq |
| Vertex Pharmaceuticals Incorporated | $30.16 | 2024-2025 | |
| Heron Therapeutics, INC. | $24.71 | 2021 | |
| Averitas Pharma INC. | $23.84 | 2025 | Qutenza |
| Organogenesis INC. | $23.45 | 2024 | |
| Depuy Synthes Sales INC. | $19.07 | 2025 | Na |
| Boston Scientific Corporation | $18.02 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.79 | 2025 | Juggerknotless Soft Anchor |
| Pacira Therapeutics, INC. | $17.77 | 2021 | |
| Innovation Technologies INC | $15.00 | 2025 | Irrisept |
| Endo Pharmaceuticals INC. | $14.30 | 2023 | Xiaflex |
| Electronic Waveform Lab, INC. | $6.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Duerden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.